European Nanomedicines Market Size, Share and Forecast 2021-2027
The European nanomedicines market is projected to grow at a modest CAGR of 10.9% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the rising burden of various diseases in the region. Owing to this, there has been an increased focus of the government along with other organizations regarding the development of novel treatment technologies including nanomedicines. For instance, organizations such as the European Society for Nanomedicine (ESNAM) and the European Technology Platform on Nanomedicine (ETPN) focus on promoting the research and clinical applications of nanomedicine for the betterment of humanity and the environment. Hence, the aforementioned factors are likely to drive the growth of the market in the region over the forecast period.
To Request a Sample of our Report on European Nanomedicines Market: https://www.omrglobal.com/request-sample/europe-nanomedicines-market
The European
nanomedicines market is segmented on the basis of indication type and
application. Based on the indication type, the market is segmented as
cardiovascular diseases, neurological diseases, infectious diseases,
oncological diseases, orthopedic diseases, and others. The other segment
includes urological disease and ophthalmic diseases. The cardiovascular
diseases segment is likely to hold a substantial share in the market over the
forecast period. Based on the applications, the market is segmented as drug
delivery, active implants, vaccines, diagnostic imaging, biomaterials,
regenerative medicines, and other applications. The other segment includes
tissue regeneration. The drug delivery segment is likely to hold a substantial
share in the market over the forecast period.
A
full Report of European Nanomedicines Market is Available at: https://www.omrglobal.com/industry-reports/europe-nanomedicines-market
European Nanomedicine Market Segmentation
By Indication Type
·
Cardiovascular
Diseases
·
Neurological
Diseases
·
Infectious
Diseases
·
Oncological
Diseases
·
Orthopedic
Diseases
·
Other
Diseases (Urological Disease, Ophthalmic Diseases)
By Application
·
Drug
Delivery
·
Active
Implants
·
Vaccines
·
Diagnostic
Imaging
·
Biomaterials
·
Regenerative
Medicines
·
Other
Applications (Tissue Regeneration)
Regional Analysis
·
European
·
The UK
·
Germany
·
France
·
Italy
·
Spain
Rest of European
Company Profiles
·
3M Co.
·
AstraZeneca
Plc.
·
Celgene
Corp.
·
Ferro
Corp.
·
GE Global
Research
·
Johnson
& Johnson Services Inc.
·
Luminex
Corp.
·
Merck
& Co. Inc.
·
PerkinElmer
Inc.
·
Pfizer
Inc.
·
Sanofi SA
·
Smith
& Nephew Plc
·
St. Jude
Medical Inc.
·
Stryker
Corp.
·
Thermo
Fisher Scientific Inc.
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-nanomedicines-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment